# Immune-Marker Platform for Patients With Advanced Lung Cancer

> **NCT07150598** · — · NOT_YET_RECRUITING · sponsor: **Technische Universität Dresden** · enrollment: 500 (estimated)

## Conditions studied

- NSCLC (Advanced Non-small Cell Lung Cancer)
- NSCLC Stage IIIB~IV
- NSCLC Non-small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07150598
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-06-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07150598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07150598, "Immune-Marker Platform for Patients With Advanced Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07150598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*